Last reviewed · How we verify
Celestone Soluspan (BETAMETHASONE ACETATE)
At a glance
| Generic name | BETAMETHASONE ACETATE |
|---|---|
| Drug class | Corticosteroid |
| Target | Glucocorticoid receptor |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | FDA-approved |
| First approval | 1965 |
Approved indications
- Acquired thrombocytopenia
- Acute lymphoid leukemia
- Adrenal cortical hypofunction
- Adrenogenital disorder
- Allergic rhinitis
- Angioedema
- Ankylosing spondylitis
- Articular gout
- Aspiration pneumonitis
- Asthma
- Atopic dermatitis
- Autoimmune disease
- Autoimmune hemolytic anemia
- Berylliosis
- Bursitis
- Cerebral edema
- Contact dermatitis
- Crohn's disease
- Dermatitis herpetiformis
- Disorder of eye
Common side effects
- Congestive heart failure
- Cardiac arrhythmias
- Cardiac enlargement
- Circulatory collapse
- Fluid retention
- Hypertension
- Hypertrophic cardiomyopathy in premature infants
- Myocardial rupture following recent myocardial infarction
- Pulmonary edema
- Thromboembolism
- Thrombophlebitis
- Vasculitis
Key clinical trials
- Betamethasone and Complications of Lower Third Molar Surgery (PHASE3)
- The TRIBECA Study (TRIessence/Byqlovi for Easier CAtaract Surgery) (PHASE4)
- Efficacy of Corticosteroid Injection and Nerve Hydrodissection in Carpal Tunnel Syndrome (NA)
- Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population (PHASE3)
- Periodontal Initial Treatment Combined With Glucocorticoid Therapy for Erosive Oral Lichen Planus (NA)
- Low Dose Antenatal Corticosteroids for Late Preterm Delivery (NA)
- Corticosteroids in Carpal Tunnel Syndrome. Prospective Randomised Controlled Non-inferiority Study (NA)
- Local Betamethasone Versus Triamcinolone Injection in Management of Thyroid Eye Disease (PHASE2,PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Celestone Soluspan CI brief — competitive landscape report
- Celestone Soluspan updates RSS · CI watch RSS